• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    3/23/22 11:47:49 AM ET
    $AGFY
    $AJX
    $ALPP
    $ANNX
    Farming/Seeds/Milling
    Consumer Staples
    Real Estate Investment Trusts
    Real Estate
    Get the next $AGFY alert in real time by email

     

     

    On Wednesday, 63 companies set new 52-week lows.

    Noteworthy Mentions In Today's 52-Week Lows:

    • The largest company by market cap to hit a new 52-week low was Stanley Black & Decker (NYSE:SWK).
    • Vallon Pharmaceuticals (NASDAQ:VLON) was the smallest company when considering market cap to set a new 52-week low.
    • Vicor (NASDAQ:VICR)'s stock dropped the most, trading down 19.34% to reach a new 52-week low.
    • Nuveen Municipal Value (NYSE:NUV) shares bounced back the most, actually rising 0.0% after hiting a new 52-week low.

    On Wednesday, the following stocks hit new 52-week lows:

    • Fortune Brands Home (NYSE:FBHS) stock set a new 52-week low of $79.84 on Wednesday, moving down 1.9%.
    • Sensata Technologies (NYSE:ST) stock hit a new 52-week low of $51.07. The stock was down 2.16% on the session.
    • Vicor (NASDAQ:VICR) stock hit a yearly low of $62.30. The stock was down 19.34% for the day.
    • LGI Homes (NASDAQ:LGIH) stock broke to a new 52-week low of $110.18 on Wednesday. Shares of the company traded down 7.33%.
    • MillerKnoll (NASDAQ:MLKN) shares fell to $32.73 on Wednesday, setting a new 52-week low with a shift of down 1.72%.
    • Nuveen Municipal Value (NYSE:NUV) stock drifted 0.0% (flat) on Wednesday morning to hit a new 52-week low of $9.39.
    • Winnebago Industries (NYSE:WGO) shares reached a new 52-week low of $55.17 on Wednesday morning, moving down 8.91%.
    • Usana Health Sciences (NYSE:USNA) stock achieved a new 52-week low on Wednesday morning, hitting $78.60 and moving down 1.77%.
    • Cytek Biosciences (NASDAQ:CTKB) stock hit a yearly low of $10.81. The stock was down 3.5% for the day.
    • Cue Health (NASDAQ:HLTH) shares fell to $6.95 on Wednesday, setting a new 52-week low with a shift of down 18.18%.
    • Northfield Bancorp (NASDAQ:NFBK) stock achieved a new 52-week low on Wednesday morning, hitting $14.74 and moving down 1.4%.
    • Invesco Trust (NYSE:VGM) shares set a new yearly low of $11.40 this morning. The stock was up 0.04% on the session.
    • Day One Biopharmaceutical (NASDAQ:DAWN) stock dropped to a yearly low on Wednesday of $9.22. Shares traded down 3.29%.
    • Blackrock Municipal IT (NYSE:BFK) shares were down 0.37% for the day, having made a 52-week low of $12.41.
    • Western Asset Managed (NYSE:MMU) stock hit a new 52-week low of $11.43. The stock was up 0.26% on the session.
    • Edgewise Therapeutics (NASDAQ:EWTX) shares moved down 6.31% on Wednesday to hit a new 52-week low of $9.89, drifting down 6.31%.
    • Cass Information Sys (NASDAQ:CASS) stock achieved a new 52-week low on Wednesday morning, hitting $36.12 and moving down 2.23%.
    • Inspirato (NASDAQ:ISPO) shares moved up 0.23% on Wednesday to hit a new 52-week low of $8.51, drifting up 0.23%.
    • BlackRock MuniHoldings (NYSE:MUJ) shares set a new yearly low of $13.58 this morning. The stock was up 0.26% on the session.
    • SeaSpine Holdings (NASDAQ:SPNE) shares were down 3.03% for the day, having made a 52-week low of $10.66.
    • Comtech Telecom (NASDAQ:CMTL) stock hit $15.00 on Wednesday morning, setting a new 52-week low for a change of down 2.97%.
    • RiverNorth Managed (NYSE:RMM) shares hit a yearly low of $16.89. The stock was up 0.15% on the session.
    • Highland Transcend (NYSE:HTPA) shares fell to $9.31 on Wednesday, setting a new 52-week low with a shift of down 2.52%.
    • Nuveen Enhanced Municipal (NYSE:NEV) shares fell to $12.99 on Wednesday, setting a new 52-week low with a shift of down 0.5%.
    • Miller Industries (NYSE:MLR) stock set a new 52-week low of $27.47 on Wednesday, moving up 0.02%.
    • Accuray (NASDAQ:ARAY) shares set a new yearly low of $3.15 this morning. The stock was down 3.21% on the session.
    • Delaware Investments (AMEX:VFL) stock hit a yearly low of $12.40. The stock was down 0.45% for the day.
    • Blackrock Investment (NYSE:BKN) stock hit $14.89 on Wednesday morning, setting a new 52-week low for a change of up 0.87%.
    • Great Ajax (NYSE:AJX) shares moved down 1.04% on Wednesday to hit a new 52-week low of $10.80, drifting down 1.04%.
    • Pioneer Municipal High IT (NYSE:MHI) shares set a new yearly low of $10.51 this morning. The stock was down 0.28% on the session.
    • Powell Industries (NASDAQ:POWL) stock hit $19.94 on Wednesday morning, setting a new 52-week low for a change of up 0.1%.
    • Rallybio (NASDAQ:RLYB) stock drifted down 2.78% on Wednesday morning to hit a new 52-week low of $7.30.
    • Pioneer Muni High Inc (NYSE:MAV) stock drifted down 0.2% on Wednesday morning to hit a new 52-week low of $9.84.
    • BNY Mellon Municipal Bond (NYSE:DMB) shares hit a yearly low of $12.49. The stock was down 0.24% on the session.
    • Telesat (NASDAQ:TSAT) shares hit a yearly low of $17.69. The stock was down 0.6% on the session.
    • GAN (NASDAQ:GAN) stock dropped to a yearly low on Wednesday of $4.25. Shares traded down 12.01%.
    • Alpine 4 Holdings (NASDAQ:ALPP) stock set a new 52-week low of $1.05 on Wednesday, moving 0.0% (flat).
    • CytomX Therapeutics (NASDAQ:CTMX) shares hit a yearly low of $2.82. The stock was down 3.5% on the session.
    • CarLotz (NASDAQ:LOTZ) shares fell to $1.55 on Wednesday, setting a new 52-week low with a shift of down 2.8%.
    • Hamilton Beach Brands (NYSE:HBB) shares were up 0.14% for the day, having made a 52-week low of $10.66.
    • Federated Hermes Premier (NYSE:FMN) shares hit a yearly low of $12.73. The stock was up 0.08% on the session.
    • Western Asset Municipal (NYSE:MNP) stock dropped to a yearly low on Wednesday of $13.40. Shares traded down 0.81%.
    • Annexon (NASDAQ:ANNX) stock hit a new 52-week low of $3.30. The stock was down 4.31% on the session.
    • Via Renewables (NASDAQ:VIA) shares set a new 52-week low of $8.19. The stock traded down 2.5%.
    • Agrify (NASDAQ:AGFY) stock hit $4.16 on Wednesday morning, setting a new 52-week low for a change of down 3.8%.
    • RiverNorth Opportunistic (NYSE:RMI) shares made a new 52-week low of $18.42 on Wednesday. The stock was down 0.25% for the day.
    • Blue World Acquisition (NASDAQ:BWAQ) stock broke to a new 52-week low of $9.83 on Wednesday. Shares of the company traded 0.0% (flat).
    • DUET Acquisition (NASDAQ:DUET) shares made a new 52-week low of $9.76 on Wednesday. The stock was down 0.81% for the day.
    • LiqTech International (NASDAQ:LIQT) shares reached a new 52-week low of $4.65 on Wednesday morning, moving up 1.06%.
    • Nuveen Mortgage & Inc (NYSE:JLS) stock hit a new 52-week low of $18.15. The stock was down 0.71% on the session.
    • Hill International (NYSE:HIL) stock hit a yearly low of $1.68. The stock was down 1.39% for the day.
    • Vallon Pharmaceuticals (NASDAQ:VLON) stock hit $2.09 on Wednesday morning, setting a new 52-week low for a change of up 2.28%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $AGFY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGFY
    $AJX
    $ALPP
    $ANNX

    CompanyDatePrice TargetRatingAnalyst
    CytomX Therapeutics Inc.
    $CTMX
    3/16/2026$12.00Neutral → Overweight
    Analyst
    Day One Biopharmaceuticals Inc.
    $DAWN
    3/10/2026$21.50Buy → Neutral
    H.C. Wainwright
    MillerKnoll Inc.
    $MLKN
    2/10/2026Outperform
    William Blair
    Powell Industries Inc.
    $POWL
    1/23/2026$427.00Neutral
    Cantor Fitzgerald
    CytomX Therapeutics Inc.
    $CTMX
    1/20/2026$10.00Buy
    Guggenheim
    Via Transportation Inc.
    $VIA
    1/20/2026Equal-Weight → Overweight
    Morgan Stanley
    Day One Biopharmaceuticals Inc.
    $DAWN
    1/13/2026$34.00Buy
    TD Cowen
    Via Transportation Inc.
    $VIA
    1/13/2026$44.00Neutral → Buy
    Goldman
    More analyst ratings

    $AGFY
    $AJX
    $ALPP
    $ANNX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF EXECUTIVE OFFICER Bender Jeremy returned 1,799,031 shares to the company, closing all direct ownership in the company (SEC Form 4) (for withholding tax)

    4 - Day One Biopharmaceuticals, Inc. (0001845337) (Issuer)

    4/23/26 4:40:56 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Head of Research and Dev. Vasconcelles Michael returned 4,397 shares to the company, closing all direct ownership in the company (SEC Form 4) (withholding obligation)

    4 - Day One Biopharmaceuticals, Inc. (0001845337) (Issuer)

    4/23/26 4:39:50 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    COO and CFO York Charles N Ii returned 312,025 shares to the company, closing all direct ownership in the company (SEC Form 4) (tax withholding)

    4 - Day One Biopharmaceuticals, Inc. (0001845337) (Issuer)

    4/23/26 4:39:05 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $AJX
    $ALPP
    $ANNX
    SEC Filings

    View All

    SEC Form DEFA14A filed by Edgewise Therapeutics Inc.

    DEFA14A - Edgewise Therapeutics, Inc. (0001710072) (Filer)

    4/23/26 4:07:02 PM ET
    $EWTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Edgewise Therapeutics Inc.

    DEF 14A - Edgewise Therapeutics, Inc. (0001710072) (Filer)

    4/23/26 4:06:20 PM ET
    $EWTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 25-NSE filed by Day One Biopharmaceuticals Inc.

    25-NSE - Day One Biopharmaceuticals, Inc. (0001845337) (Subject)

    4/23/26 9:14:52 AM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $AJX
    $ALPP
    $ANNX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    April 30, 2024 - FDA Roundup: April 30, 2024

    For Immediate Release: April 30, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “A Milestone in Facilitating the Development of Safe and Effective Biosimilars,” by Sarah Yim, Director of the Office of New Drugs’ Office of Therapeutic Biologics and Biosimilars, Hilary Marston, M.D., M.P.H., and Patriz

    4/30/24 3:20:20 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    April 26, 2024 - FDA Roundup: April 26, 2024

    For Immediate Release: April 26, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “A Milestone in Facilitating the Development of Safe and Effective Biosimilars,” by Sarah Yim, Director of the Office of New Drugs’ Office of Therapeutic Biologics and Biosimilars, Hilary Marston, M.D., M.P.H., and Patriz

    4/26/24 3:10:22 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for OJEMDA issued to DAY ONE BIOPHARMACEUTICALS INC

    Submission status for DAY ONE BIOPHARMACEUTICALS INC's drug OJEMDA (ORIG-1) with active ingredient TOVORAFENIB has changed to 'Approval' on 04/23/2024. Application Category: NDA, Application Number: 218033, Application Classification: Type 1 - New Molecular Entity

    4/24/24 12:52:43 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $AJX
    $ALPP
    $ANNX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026

    FREMONT, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), today announced that it will report financial results for the first quarter 2026 after market close on Thursday, May 7, 2026. The company's management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the "Investors" section of the company website at investors.cytekbio.com. About Cytek Biosciences, Inc.Cytek Biosciences (NASDAQ:CTKB) is a leading cell analysis solutions company advancing the next generation

    4/23/26 4:05:00 PM ET
    $CTKB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    New DEWALT Study Identifies Emerging Gap Between AI Training in Trade Schools and Industry Needs

    Survey cites that while the majority of construction pros believe AI will be indispensable within five years, only 8% are currently using AI on the jobMajority of construction pros say AI training must be embedded in trade schoolsDEWALT is launching a pilot program and AI Education Grant in partnership with Associated Builders and Contractors to support the need for AI training enabling skilled workers to focus on what they do best – buildingTOWSON, Md., April 23, 2026 /PRNewswire/ -- As artificial intelligence (AI) rapidly transforms industries and becomes an essential jobsite tool for construction and industrial businesses, a new national study from DEWALT, Stanley Black & Decker's (NYSE:S

    4/23/26 9:00:00 AM ET
    $SWK
    Industrial Machinery/Components
    Consumer Discretionary

    Servier completes the acquisition of Day One Biopharmaceuticals

    Acquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S. in pediatric low-grade glioma. Transaction also includes a strong oncology pipeline of clinical stage assets in rare cancers with high unmet needs. Transaction represents total equity value of approximately $2.5 billion.SURESNES, France, April 23, 2026 /CNW/ -- Servier, an independent international pharmaceutical group governed by a foundation, today announced the successful completion of the tender offer to acquire all of the issued and outstanding shares of common stock of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) ("Day One"), a biopharmaceutical company dedicated to developing and com

    4/23/26 8:30:00 AM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $AJX
    $ALPP
    $ANNX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Carson William H. bought $45,360 worth of shares (8,000 units at $5.67), increasing direct ownership by 15% to 62,405 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    3/12/26 4:31:34 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO Von Schuckmann Stephan bought $501,671 worth of Ordinary Shares (15,150 units at $33.11), increasing direct ownership by 15% to 118,938 units (SEC Form 4)

    4 - Sensata Technologies Holding plc (0001477294) (Issuer)

    3/10/26 4:19:47 PM ET
    $ST
    Industrial Machinery/Components
    Industrials

    Director Mayer Steven F bought $30,878 worth of shares (54,875 units at $0.56), increasing direct ownership by 4% to 1,545,620 units (SEC Form 4)

    4 - ACCURAY INC (0001138723) (Issuer)

    2/23/26 4:10:08 PM ET
    $ARAY
    Medical/Dental Instruments
    Health Care

    $AGFY
    $AJX
    $ALPP
    $ANNX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CytomX Therapeutics upgraded by Analyst with a new price target

    Analyst upgraded CytomX Therapeutics from Neutral to Overweight and set a new price target of $12.00

    3/16/26 11:34:14 AM ET
    $CTMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Day One Biopharmaceuticals downgraded by H.C. Wainwright with a new price target

    H.C. Wainwright downgraded Day One Biopharmaceuticals from Buy to Neutral and set a new price target of $21.50

    3/10/26 8:39:03 AM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    William Blair initiated coverage on MillerKnoll

    William Blair initiated coverage of MillerKnoll with a rating of Outperform

    2/10/26 8:01:31 AM ET
    $MLKN
    Office Equipment/Supplies/Services
    Consumer Discretionary

    $AGFY
    $AJX
    $ALPP
    $ANNX
    Leadership Updates

    Live Leadership Updates

    View All

    Cass Information Systems, Inc. Announces Appointment of John Drabik to Board of Directors and Retirements of Sally Roth, Ralph Clermont and Jim Lindemann

    ST. LOUIS, April 22, 2026 (GLOBE NEWSWIRE) -- Cass Information Systems, Inc. (NASDAQ:CASS) (the "Company"), a leading provider of payment processing and information solutions, today announced changes to its Board of Directors, effective April 21, 2026. John J. Drabik was elected as a member of the Board and also appointed to serve on the Company's Audit and Risk Committee. Mr. Drabik is Executive Vice President and Chief Financial Officer of Energizer Holdings, Inc., where he oversees global finance, accounting, investor relations and information technology. He has been with Energizer and its predecessor organization since 2001 and has held senior leadership roles across corporate develop

    4/22/26 9:00:00 AM ET
    $CASS
    Real Estate

    Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer

    MADISON, Wis., April 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced the appointment of Paul Miele as Senior Vice President and Chief Commercial Officer, effective April 6, 2026. Miele will join Accuray's executive leadership team and lead the company's global commercial organization as Accuray continues to advance its transformation and strengthen execution across its portfolio. "Paul brings deep global commercial leadership experience and a strong track record of driving transform

    4/6/26 9:00:00 AM ET
    $ARAY
    Medical/Dental Instruments
    Health Care

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    $AGFY
    $AJX
    $ALPP
    $ANNX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Federated Hermes Premier Municipal Income Fund

    SC 13D/A - Federated Hermes Premier Municipal Income Fund (0001199004) (Subject)

    12/13/24 5:01:17 PM ET
    $FMN
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by Pioneer Municipal High Income Advantage Fund Inc.

    SC 13D/A - PIONEER MUNICIPAL HIGH INCOME ADVANTAGE FUND, INC. (0001258943) (Subject)

    12/13/24 4:29:08 PM ET
    $MAV
    Finance Companies
    Finance

    Amendment: SEC Form SC 13D/A filed by Pioneer Municipal High Income Fund Inc.

    SC 13D/A - PIONEER MUNICIPAL HIGH INCOME FUND, INC. (0001223026) (Subject)

    12/13/24 4:29:09 PM ET
    $MHI
    Investment Managers
    Finance

    $AGFY
    $AJX
    $ALPP
    $ANNX
    Financials

    Live finance-specific insights

    View All

    Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026

    FREMONT, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), today announced that it will report financial results for the first quarter 2026 after market close on Thursday, May 7, 2026. The company's management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the "Investors" section of the company website at investors.cytekbio.com. About Cytek Biosciences, Inc.Cytek Biosciences (NASDAQ:CTKB) is a leading cell analysis solutions company advancing the next generation

    4/23/26 4:05:00 PM ET
    $CTKB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Cass Information Systems reports First Quarter 2026 Results

    Reports another quarter of strong EPS growth Continued net interest margin expansion Strong expense control ST. LOUIS, April 23, 2026 (GLOBE NEWSWIRE) -- Cass Information Systems, Inc. (NASDAQ:CASS) (the Company or Cass) today reported its first quarter 2026 earnings. First Quarter Financial Highlights Net income and diluted earnings per share of $8.8 million and $0.67, respectively.Adjusted net income and adjusted diluted earnings per share from continuing operations of $8.7 million and $0.66, respectively, increases of 23.7% and 26.9%, respectively, compared to the prior year quarter.Increase in net interest margin to 3.95%, compared to 3.75% in the prior year quarter.Increase in fa

    4/23/26 8:00:00 AM ET
    $CASS
    Real Estate

    Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

    MADISON, Wis., April 22, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026. The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), c

    4/22/26 4:05:00 PM ET
    $ARAY
    Medical/Dental Instruments
    Health Care